Literature DB >> 6247279

Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus.

M Ho.   

Abstract

Cytotoxic lymphocytes were generated in vitro against murine cytomegalovirus (MCMV)-infected cells by incubation with ultraviolet light-irradiated, infected fibroblasts. When passively transferred, they reduced virus titers in spleens of mice 1 day after infection with MCMV. Protection was abrogated by anti-theta serum and complement. Spleen cells from mice infected for 6 to 14 days protected mice better than cells from mice after infection for 1, 3, or 30 days. Protection by in vitro- and in vivo-generated cells was H-2K or H-2D restricted. Specific cytotoxic T lymphocytes are therefore present and operative during acute MCMV infection. However, MCMV infection inhibited the development of primary cytotoxic response against ectromelia virus. It also suppressed the ability of lymphocytes from mice with established memory for ectromelia to develop secondary cytotoxic cells in vitro, and it inhibited the development of memory cells for the cytotoxic response to ectromelia virus. In view of these data and the inability of animals recovering from MCMV infection to eliminate all infected cells, the cytotoxic response to MCMV may be qualitatively or quantitatively deficient.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247279      PMCID: PMC550838          DOI: 10.1128/iai.27.3.767-776.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  A procedure for removing red cells and dead cells from lymphoid cell suspensions.

Authors:  W F Davidson; C R Parish
Journal:  J Immunol Methods       Date:  1975-06       Impact factor: 2.303

Review 2.  Infection with herpes-simplex viruses 1 and 2. 3.

Authors:  A J Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1973-10-11       Impact factor: 91.245

3.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

4.  Enhancement of infectivity of murine cytomegalovirus in vitro by centrifugal inoculation.

Authors:  J E Osborn; D L Walker
Journal:  J Virol       Date:  1968-09       Impact factor: 5.103

5.  Allogeneic stimulation modulates the in vitro response of T cells to transplantation antigen.

Authors:  K J Lafferty; I S Misko; M A Cooley
Journal:  Nature       Date:  1974-05-17       Impact factor: 49.962

6.  Immunosuppression during acute murine cytomegalovirus infection.

Authors:  J E Osborn; A A Blazkovec; D L Walker
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

7.  Suppression of interferon and antibody and multiplication of Newcastle disease virus in cytomegalovirus infected mice.

Authors:  J E Osborn; D N Medearis
Journal:  Proc Soc Exp Biol Med       Date:  1967-02

8.  Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics.

Authors:  I Gardner; N A Bowern; R V Blanden
Journal:  Eur J Immunol       Date:  1974-02       Impact factor: 5.532

Review 9.  T cell response to viral and bacterial infection.

Authors:  R V Blanden
Journal:  Transplant Rev       Date:  1974

10.  Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction.

Authors:  L B Olding; F C Jensen; M B Oldstone
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

View more
  23 in total

Review 1.  CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.

Authors:  Rafaela Holtappels; Verena Böhm; Jürgen Podlech; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2008-03-15       Impact factor: 3.402

Review 2.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

Review 3.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

4.  Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.

Authors:  M J Reddehase; F Weiland; K Münch; S Jonjic; A Lüske; U H Koszinowski
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

5.  Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.

Authors:  R C Gehrz; S R Rutzick
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

6.  Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720).

Authors:  A A Scalzo; S L Elliott; J Cox; J Gardner; D J Moss; A Suhrbier
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Effect of murine cytomegalovirus infection on mitogen responses in genetically resistant and susceptible mice.

Authors:  J E Allan; G R Shellam; J E Grundy
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

8.  Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication.

Authors:  G V Quinnan; J F Manischewitz
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

Review 9.  Mouse models in bone marrow transplantation and adoptive cellular therapy.

Authors:  Caroline Arber; Malcolm K Brenner; Pavan Reddy
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

10.  Murine cytomegalovirus-induced immunosuppression.

Authors:  L Loh; J B Hudson
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.